BNTC
Benitec Biopharma Inc

6,332
Mkt Cap
$412.6M
Volume
95,809.00
52W High
$17.15
52W Low
$9.85
PE Ratio
-12.92
BNTC Fundamentals
Price
$11.75
Prev Close
$12.01
Open
$12.01
50D MA
$11.72
Beta
0.46
Avg. Volume
148,635.33
EPS (Annual)
-$1.05
P/B
2.20
Rev/Employee
$0.00
$326.64
Loading...
Loading...
News
all
press releases
Benitec Biopharma (NASDAQ:BNTC) Stock Price Crosses Above 50 Day Moving Average - What's Next?
Benitec Biopharma (NASDAQ:BNTC) Stock Price Passes Above Fifty Day Moving Average - Time to Sell...
MarketBeat·21h ago
News Placeholder
More News
News Placeholder
Benitec Biopharma Reports Promising Interim Results For BB-301 Gene Therapy In OPMD Trial
(RTTNews) - Benitec Biopharma Inc. (BNTC) on Monday, announced encouraging interim results from its Phase 1b/2a clinical study evaluating BB-301, a gene therapy for Oculopharyngeal Muscular Dystrophy...
Nasdaq News: Markets·8d ago
News Placeholder
Benitec Biopharma's (BNTC) "Buy" Rating Reaffirmed at HC Wainwright
HC Wainwright reiterated a "buy" rating and issued a $32.00 price target on shares of Benitec Biopharma in a research report on Monday...
MarketBeat·9d ago
News Placeholder
HC Wainwright Issues Optimistic Forecast for BNTC Earnings
Benitec Biopharma Limited (NASDAQ:BNTC - Free Report) - Equities researchers at HC Wainwright boosted their Q3 2026 earnings per share estimates for Benitec Biopharma in a research report issued on...
MarketBeat·13d ago
News Placeholder
Analysts Issue Forecasts for BNTC Q1 Earnings
Benitec Biopharma Limited (NASDAQ:BNTC - Free Report) - Investment analysts at HC Wainwright issued their Q1 2027 earnings per share estimates for shares of Benitec Biopharma in a research report...
MarketBeat·14d ago
News Placeholder
Benitec Biopharma Limited (NASDAQ:BNTC) Receives Consensus Rating of "Moderate Buy" from Brokerages
Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven analysts that are covering the stock, MarketBeat.com reports. One...
MarketBeat·18d ago
News Placeholder
Benitec Biopharma (NASDAQ:BNTC) Shares Cross Below 50-Day Moving Average - Here's Why
Benitec Biopharma (NASDAQ:BNTC) Share Price Passes Below 50-Day Moving Average - Time to Sell...
MarketBeat·21d ago
News Placeholder
Wall Street Zen Downgrades Benitec Biopharma (NASDAQ:BNTC) to Sell
Wall Street Zen downgraded Benitec Biopharma from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·1mo ago
News Placeholder
Benitec Biopharma (NASDAQ:BNTC) Announces Quarterly Earnings Results
Benitec Biopharma (NASDAQ:BNTC - Get Free Report) issued its quarterly earnings results on Thursday. The biotechnology company reported ($0.26) earnings per share (EPS) for the quarter, missing...
MarketBeat·1mo ago
News Placeholder
Benitec Biopharma (BNTC) Projected to Post Earnings on Friday
Benitec Biopharma (NASDAQ:BNTC) will be releasing its Q2 2026 earnings before the market opens on Friday, February 13. (View Earnings Report at...
MarketBeat·1mo ago
<
1
2
...
>

Latest BNTC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.